Elucirem™ (Gadopiclenol)
MRI contrast agent (CNS, body)
Key Facts
About Guerbet
Guerbet is a 100-year-old, publicly traded French pharmaceutical company focused exclusively on medical imaging. It offers a comprehensive portfolio of contrast media and solutions for X-ray, MRI, and interventional radiology, with a strategic emphasis on innovation and a proactive CSR approach. The company generates significant revenue from its commercial products, maintains a strong family-led governance, and is actively expanding indications for its key assets, such as the recent pediatric approval for Elucirem™ in Europe.
View full company profileAbout Guerbet
Guerbet is a 100-year-old, publicly traded French pharmaceutical company focused exclusively on medical imaging. It offers a comprehensive portfolio of contrast media and solutions for X-ray, MRI, and interventional radiology, with a strategic emphasis on innovation and a proactive CSR approach. The company generates significant revenue from its commercial products, maintains a strong family-led governance, and is actively expanding indications for its key assets, such as the recent pediatric approval for Elucirem™ in Europe.
View full company profile